univariate analysis

Related by string. Univariate analysis * Univariate : univariate analyzes . univariate / analy sis . ANALYSIS . Analysis : Chart Analysis News . Strategic Analysis Review . Electronic Document Analysis . detailed SWOT analysis . Detailed Analysis . SWOT analysis corporate . analysis . SWOT analysis Strengths Weaknesses . SWOT Analysis examines . ICP AES analysis . depicts Gartner analysis * *

Related by context. Frequent words. (Click for all words.) 75 multivariate analysis 71 covariates 71 P = .# 69 % CI #.#-#.# [006] 68 PCa 67 ANOVA 67 % CI #.#-#.# [002] 67 p = #.# [002] 67 confidence interval CI 67 confidence interval #.#-#.# 67 logistic regression 66 serum concentrations 65 histologic 65 nonsignificant 65 comorbidity 64 neoadjuvant chemotherapy 64 lymph node involvement 64 fasting insulin 64 mRNA expression 63 distant metastases 63 prognostic factors 63 subgroup analyzes 63 glomerular filtration rate 63 preoperative 63 nephrectomy 63 D dimer 63 p = 63 proportional hazards 62 comorbidities 62 prognostic factor 62 mg kg dose 62 rs# [003] 62 median PFS 62 ± SD 62 62 virologic failure 62 virologic response 61 DAS# [002] 61 vertebral fracture 61 CaP 61 p = #.# [004] 61 cystatin C 61 laboratory abnormalities 61 Preoperative 61 IPSS 60 Secondary endpoints 60 subscales 60 Main Outcome Measures 60 comorbid conditions 60 nonresponders 60 estrogen receptor ER 60 CI = 60 genotypic 60 nmol L 60 neoadjuvant 60 potential confounders 60 pathologic 60 confounders 59 statistically significant 59 microalbuminuria 59 eGFR 59 leukopenia 59 Postoperative 59 LVEF 59 adenoma 59 malignant lesions 59 Recurrence Score 59 Secondary endpoints included 59 postoperative complications 59 serum creatinine 59 pg mL 59 oral glucose tolerance 58 evaluable 58 preoperatively 58 statistically significant p 58 ADAS cog 58 DMARD 58 NT proBNP 58 proteinuria 58 strongest predictor 58 nonadherence 58 luminal 58 FDG PET 58 secondary efficacy endpoints 58 HRQOL 58 creatinine clearance 58 epithelial ovarian cancer 58 reach statistical significance 58 contralateral 58 composite endpoint 58 adjuvant chemotherapy 58 HbA1c levels 58 neoplastic 58 Secondary endpoints include 58 prespecified 58 Disease Activity 57 RECIST criteria 57 multivariable 57 statistically significant differences 57 differentially expressed 57 histological

Back to home page